Medical News

RSS

GAVI says pentavalent vaccine price to fall, but $3.7B still needed to vaccinate children in developing countries

The average price of a vaccine that protects children against five diseases is expected to "drop to $2.58 next year compared to the current average price of $2.97," the GAVI Alliance said Friday, Reuters reports. The group credits the expected price decline, which "represents a decrease of 30 percent over the last seven years," in part to an "increased demand for the pentavalent, or five-in-one vaccine," according to the news service (Kelland, 11/26).

30 Nov 2010

Haiti requires additional trained nurses, doctors to address cholera epidemic, U.N. official says

Haiti needs about 1,000 additional trained nurses and at least 100 more physicians to control the cholera epidemic, Valerie Amos, the U.N. undersecretary-general for humanitarian affairs, said during a recent visit to the capital of Port-au-Prince, Reuters reports.

30 Nov 2010

New chest X-ray technology enhances lung nodule detection

Riverain Medical, an industry leader and innovator in computer-aided detection (CAD) and advanced visualization technologies, today announced its SoftView Enhanced Chest Imaging and OnGuard Chest X-ray Computer-Aided Detection (CAD) technologies can now integrate In Unison for improved workflow and enhanced lung nodule detection.

30 Nov 2010

Siemens to distribute Rcadia's COR Analyzer System

Rcadia Medical Imaging and Siemens Healthcare have entered into an agreement for Siemens to distribute Rcadia's COR Analyzer® System. The COR Analyzer's ability to identify stenotic lesions in Coronary Computed Tomography Angiography (cCTA) studies in combination with Siemens' Syngo®.via CT Cardio-Vascular Engine provides a comprehensive solution for evaluating suspected cardiac patients. The integration of both systems realizes a seamless workflow with enhanced productivity.

30 Nov 2010

Medivation, Astellas enroll 1,199 patients in MDV3100 Phase 3 AFFIRM study in advanced prostate cancer

Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.

30 Nov 2010

Apricus announces publication of NexACT technology data in Pharmaceutics Journal

Apricus Biosciences, Inc., announced today that the International Journal of Pharmaceutics, a peer reviewed journal, has published new data on the NexACT technology in their November 2010 issue, based on research conducted by, and at, the Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey in Piscataway, NJ.

30 Nov 2010

Study: Mature blood cells communicate with parent stem cells

A new study by researchers at the Walter and Eliza Hall Institute in Melbourne, Australia, has shown that mature blood cells can communicate with, and influence the behaviour of, their stem cell 'parents'.

30 Nov 2010

To reduce spread of HIV/AIDS, IFRC calls for more focus on IDU programs

Ahead of World AIDS Day, the International Federation of the Red Cross on Friday released a report (.pdf) calling for governments around the world to do more to help stop the spread of HIV/AIDS among populations of injecting drug users (IDUs), the Associated Press reports (Heilprin, 11/25).

30 Nov 2010

Support elusive for debt panel as Wednesday deadline nears

The chairmen of a bipartisan panel appointed by President Barack Obama are altering an early draft of recommendations to reduce the nation's debt, in hopes of attracting broader support, The Wall Street Journal reports. Democrat Erskine Bowles and Republican (former) Sen. Alan Simpson "need 14 of the 18 members of the National Commission on Fiscal Responsibility and Reform to support their proposal in order to issue a formal recommendation, which could then be voted on by Congress before the end of the year.

30 Nov 2010

Overexpression of microRNA 125b can cause leukemia: Research

Whitehead Institute researchers have shown in mouse models that overexpression of the microRNA 125b (miR-125b) can independently cause leukemia and accelerate the disease's progression. Their results are published in this week's online edition of the Proceedings of the National Academy of Sciences (PNAS).

30 Nov 2010

Array BioPharma to present data on ARRY-520 Phase 1 trial for multiple myeloma at ASH Annual Meeting

Array BioPharma Inc. today announced that it will present data from a Phase 1 trial of KSP inhibitor ARRY-520 in patients with relapsed/refractory multiple myeloma at the 2010 Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida on Saturday, December 4, 2010.

30 Nov 2010

Gen-Probe submits PMA to FDA for APTIMA HPV assay to detect cervical cancer

Gen-Probe Incorporated announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its APTIMA® HPV (human papillomavirus) assay, a new molecular test that detects high-risk HPV infections that are associated with cervical cancer and precancerous lesions.

30 Nov 2010

Calistoga to feature data on CAL-101 inhibitor for hematologic malignancies at ASH Annual Meeting

Calistoga Pharmaceuticals, Inc., the leader in the development of delta-isoform-selective phosphatidylinositol 3-kinase (PI3K-delta) inhibitors for the treatment of cancer and inflammatory diseases, today announced the upcoming presentation of clinical and preclinical results supporting the clinical benefit of CAL-101, an oral, PI3K-delta inhibitor, in the treatment of patients with hematologic malignancies.

30 Nov 2010

Medicare advantage enrollees will see more changes to plans

Medicare Advantage enrollees should make a habit of evaluating their options each year. Though experts say that beneficiaries won't be seeing a lot of changes this time and what changes there are will mostly be for the better it is a good idea for people to go through this annual drill before enrollment ends Dec. 31, just to make sure their plan choice remains a good one.

30 Nov 2010

Scientists discover M3-protein can help maintain blood sugar levels

Medical scientists at the University of Leicester have identified for the first time a new way in which our body controls the levels of sugar in our blood following a meal.

30 Nov 2010

Hana Biosciences to present Marqibo data for acute lymphoblastic leukemia at ASH Annual Meeting

Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that data regarding Marqibo for treatment of adults with relapsed/refractory acute lymphoblastic leukemia (ALL) will be the subject of two presentations at the 2010 Annual Meeting and Exposition of the American Society of Hematology (ASH) being held in Orlando, Florida from December 4-7, 2010.

30 Nov 2010

Alza files patent infringement suit against Impax in connection with Concerta

Impax Laboratories, Inc. today confirms that Alza Corporation has filed suit for patent infringement against Impax in the United States District Court for the District of Delaware in connection with Concerta® (methylphenidate hydrochloride) extended-release 54 mg tablets.

30 Nov 2010

Tricare may raise fees; VA Medical Center uses telemedicine to trim costs

"Of nearly 4.5 million military retirees and their families, about three-quarters are estimated to have access to health insurance through a civilian employer or group. But more than two million of them stay on Tricare," the military's lifetime health insurance program, The New York Times reports. Enrollment in Tricare, which costs less than what many private employers ask for in premiums, is expected to grow "as the costs of private health care continue to climb."

29 Nov 2010

FDA approves Axiron topical solution CIII for testosterone replacement therapy in men

Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.

29 Nov 2010

SuperSonic Imagine receives €19 million from historical investors

SuperSonic Imagine's historical investors, Edmond de Rothschild Investment Partners, Auriga Partners, Crédit Agricole Private Equity, NBGI Ventures, BioAm (managed by CDC Entreprises), Wellington Partners and IXO Private Equity, reiterated their strong support through a combined investment of €19 million in this round.

29 Nov 2010

Medical News

GAVI says pentavalent vaccine price to fall, but $3.7B still needed to vaccinate children in developing countries

Haiti requires additional trained nurses, doctors to address cholera epidemic, U.N. official says

New chest X-ray technology enhances lung nodule detection

Siemens to distribute Rcadia's COR Analyzer System

Medivation, Astellas enroll 1,199 patients in MDV3100 Phase 3 AFFIRM study in advanced prostate cancer

Apricus announces publication of NexACT technology data in Pharmaceutics Journal

Study: Mature blood cells communicate with parent stem cells

To reduce spread of HIV/AIDS, IFRC calls for more focus on IDU programs

Support elusive for debt panel as Wednesday deadline nears

Overexpression of microRNA 125b can cause leukemia: Research

Array BioPharma to present data on ARRY-520 Phase 1 trial for multiple myeloma at ASH Annual Meeting

Gen-Probe submits PMA to FDA for APTIMA HPV assay to detect cervical cancer

Calistoga to feature data on CAL-101 inhibitor for hematologic malignancies at ASH Annual Meeting

Medicare advantage enrollees will see more changes to plans

Scientists discover M3-protein can help maintain blood sugar levels

Hana Biosciences to present Marqibo data for acute lymphoblastic leukemia at ASH Annual Meeting

Alza files patent infringement suit against Impax in connection with Concerta

Tricare may raise fees; VA Medical Center uses telemedicine to trim costs

FDA approves Axiron topical solution CIII for testosterone replacement therapy in men

SuperSonic Imagine receives €19 million from historical investors

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News